Microfluidic Single-Cell Analysis & Screening System Market Size and Trends - Global Forecast 2026-2032 | AI Automation and Precision Medicine Drive 9.82% CAGR Toward USD 1.50 Billion
Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Microfluidic Single-Cell Analysis & Screening System Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
This market research report examines the global Microfluidic Single-Cell Analysis & Screening System Market, which is projected to reach USD 861.59 million in 2026 and grow at a CAGR of 9.82% to USD 1.50 billion by 2032. It evaluates technologies, workflows, applications, adoption barriers, regional dynamics, and strategic priorities shaping the market. The insights support investment planning, platform selection, and identification of opportunities across research, clinical, and drug-development environments.
Market Overview
Microfluidic single-cell analysis and screening systems combine microscale fluid handling, cell isolation, imaging, molecular assays, and computational analysis to characterize individual cells. These systems are especially valuable when population averages conceal rare subpopulations, treatment responses, cell-state differences, or cell-to-cell variability.
Workflow Integration and Technology Development
The market is progressing from standalone microfluidic devices toward integrated workflows connecting sample preparation, partitioning, stimulation, detection, sequencing or imaging, and analysis. Automation is reducing manual intervention and improving consistency, while droplet, chamber, valve, and digital microfluidic designs are expanding assay compatibility.
Analysis of workflow requirements enables decision-makers to compare platforms based on practical use-case fit rather than headline functionality, supporting more effective procurement and market-entry strategies.
Artificial Intelligence and Advanced Analytics
Artificial intelligence is influencing image segmentation, phenotype classification, anomaly detection, feature extraction, experimental design, and multimodal data integration. Machine-learning tools can identify rare cellular states, quantify morphological changes, and connect phenotypic observations with molecular measurements.
Market participants can use these insights to prioritize analytics capabilities while mitigating risks associated with biased training data, model drift, limited interpretability, privacy requirements, and insufficient validation.
Regional Market Dynamics
Economic Groups and Country Opportunities
ASEAN markets are advancing biomedical research and healthcare modernization, while BRICS countries prioritize domestic technology capacity and affordable workflows. The European Union stresses reproducibility, data protection, and cross-border interoperability. G7 markets combine mature research ecosystems with strong demand for automation and validated analytics, while GCC states are investing in genomics and healthcare transformation.
Country-level coverage highlights distinct opportunities across Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States. These comparisons inform geographic expansion decisions by clarifying differences in infrastructure, funding, procurement, regulation, and technical capability.
Strategic Priorities for Market Participants
Key Takeaways from This Report
Key Topics Covered
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Microfluidic Single-Cell Analysis & Screening System Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Chips
7.2.2. Reagents
7.3. Instruments
7.3.1. Benchtop
7.3.2. Portable
8. Microfluidic Single-Cell Analysis & Screening System Market, by Technology
8.1. Introduction
8.2. Flow Cytometry Based
8.3. Microarray Based
8.4. Pcr Based
8.5. Sequencing Based
9. Microfluidic Single-Cell Analysis & Screening System Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.3. Microbial Cells
9.4. Plant Cells
10. Microfluidic Single-Cell Analysis & Screening System Market, by Application
10.1. Introduction
10.2. Cancer Research
10.3. Drug Discovery
10.4. Immunology
10.5. Personalized Medicine
10.6. Stem Cell
11. Microfluidic Single-Cell Analysis & Screening System Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Clinical Laboratories
11.4. Contract Research Organizations
11.5. Pharma And Biotechnology Companies
12. Microfluidic Single-Cell Analysis & Screening System Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Microfluidic Single-Cell Analysis & Screening System Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Microfluidic Single-Cell Analysis & Screening System Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 10x Genomics, Inc.
16.2. Agilent Technologies, Inc.
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. Celsee, Inc. (a part of Bio-Rad Laboratories, Inc.)
16.6. Cherry Biotech SAS
16.7. Cytena GmbH (a part of BICO Group AB)
16.8. Dolomite Bio (a part of Blacktrace Holdings Ltd.)
16.9. Dolomite Microfluidics (a part of Blacktrace Holdings Ltd.)
16.10. Elveflow
16.11. Fluidigm Corporation
16.12. Fluxion Biosciences, Inc.
16.13. Illumina, Inc.
16.14. Micronit B.V.
16.15. Mission Bio, Inc.
16.16. NanoString Technologies, Inc.
16.17. On-chip Biotechnologies Co., Ltd.
16.18. Standard BioTools Inc.
16.19. Vycap B.V.
17. Key Experts
LIST OF FIGURES [21]
LIST OF TABLES [289]
For more information about this report visit https://www.researchandmarkets.com/r/w9mq9v
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.